Gilead Sciences, Inc.'s High Bar for AIDS Drugs Means New Development Withers

March 14 (Bloomberg) -- Gilead Sciences Inc., the world's biggest AIDS-drug maker, revolutionized treatment and helped forge a $15 billion market with a single daily pill attacking the virus with three medicines at once.